John Austin
Analyst · Barclays
Great. Thank you, Chris and good afternoon, everyone. Our net sales for the quarter ended June 30, 2017, increased approximately 13.9% to $331.7 million, from the $291.2 million, for the second quarter ended June 24, 2016. The increase in net sales was the result of organic growth of approximately 10% as well as the contribution of sales from the MT acquisition which added approximately 4% to sales growth for the quarter. Inflation continued to increase sequentially during the quarter to approximately 3.8%, consisting of 4.3% inflation in our specialty division and inflation of 2.9% in our protein division. That rate of inflation is slightly ahead of our expectations when we started 2017, particularly in proteins. But that cadence of a sequentially improving inflationary environment is consistent with our overall outlook. Gross profit increased approximately 15.0% to $82.6 million for the second quarter of 2017 versus $71.8 million for the second quarter of 2016. Gross profit margins increased approximately 24 basis points to 24.9% from 24.7% which benefited from the increase in mix from our business -- derived from our specialty business. Our gross margins in our specialty division increased approximately 12 basis points, inclusive of the impact of the MT acquisition which had a slightly lower-margin profile than our chefs margins. Gross profit margins also increased by 12 basis points in our protein division. We were able to effectively manage the impact of inflation on our gross margins, although we did see a lag in passing that through in our protein division. As expected, we have seen a slight uptick in gross margins in July for most of our protein businesses, although prime continues to be a very difficult market. Overall, we're encouraged with the improvement we're seeing in that segment of our business. The total operating expense increased approximately 16.2% to $70.4 million for the second quarter of 2017, from $60.6 million for the second quarter of 2016. As a percentage of net sales, operating expenses were 21.2% for the second quarter of '17 compared to 20.8% for the prior year second quarter. The increase in the operating expense ratio is larger attributable to the impact of the prior year gain upon the reduction of earnout liabilities of $1.5 million, increased warehouse labor cost of approximately $1.3 million, higher fleet-related expenses of $1.3 million and higher compensation costs related to the company's management infrastructure of $2.1 million, an increase bad debt expense of approximately $0.5 million, offset in part by leverage on the company's facility cost and reduced workman's comp and health insurance costs. Adjusted for onetime cost, our net operating expense ratio was approximately flat versus the prior year quarter. Operating income for the second quarter of 2017 was $12.2 million compared to $11.2 million for the second quarter of the prior year. Interest expense decreased to $5.9 million versus $25.7 million for the prior year second quarter related to the $22.3 million of onetime financing costs associated with the refinancing we completed last June. Exclusive of that prior year prepayment penalty, interest expense increased as a result of the higher levels of debt as well as a higher interest rate on our debt facilities related to the new debt facilities. Income tax expense was $2.6 million for the second quarter of 2017 compared to an income tax benefit of $6.0 million for the second quarter of 2016. Our effective tax rate was approximately 41.5% during the quarter. Our GAAP income was $3.7 million or $0.14 per diluted share for the second quarter of 2017 compared to a net loss of $8.5 million or $0.33 per diluted share for the second quarter of 2016. On a non-GAAP basis, adjusted EBITDA was $18.1 million for the second quarter of '17 compared to $15.3 million for the prior year second quarter. Modified pro forma net income was $3.7 million and modified pro forma income per share was $0.14 for the second quarter of 2017 compared to modified pro forma net income of $3.9 million or $0.15 per share for the prior year second quarter. We continue to benefit from strong cash flow and delever our balance sheet nicely during the quarter. We finished the quarter with an adjusted net debt-to-EBITDA of 4.8x. Consequently the interest rate on our Term B facility will decrease prospectively by 1%. And turning to our guidance for 2017. We're updating our financial guidance as follows, we estimate that net sales for the full year of 2017 will be in the range of $1.28 billion to $1.29 million; gross profit to be between $325 million and $330 million; net income to be between $9.8 million and $10.8 million; GAAP net income per diluted share to be between $0.37 and $0.41 per share; and adjusted EBITDA, we expect to be between $64.0 million and $66.4 million; and pro forma net income per diluted share to be between $0.38 and $0.42 per share. This guidance is based on an effective tax rate of approximately 41.5% for 2017. And in addition, our estimated diluted share count of approximately 26.5 million shares, note that the convertible shares are right at the cusp of the being dilutive and anti-dilutive. So as you see in the second quarter, the dilutive shares from the convertible notes are included in our share base. We expect them not to be dilutive for the full year and therefore, we think 26.5 million is the correct approximate diluted share count. With that, operator, we'll turn it over for questions.